Most bought healthcare stocks in Q2 2018
See which Healthcare stocks institutional investors increased the most in Q2 2018, measured as net growth in reported share positions from Q1 2018 into Q2 2018. Notable additions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), ELI LILLY & CO (LLY), TEVA PHARMACEUTICAL-SP ADR (TEVA), PFIZER INC (PFE). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 4,834,067 | $15.34M | 1 | 4 | 2 | 1 | 10 |
| LLY | ELI LILLY & CO | 4,207,277 | $570.95M | 0 | 2 | 3 | 0 | 6 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 3,105,786 | $527.56M | 0 | 3 | 0 | 0 | 6 |
| PFE | PFIZER INC | 2,659,720 | $110.12M | 1 | 3 | 7 | 0 | 12 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 2,497,533 | $278.01M | 1 | 0 | 1 | 0 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 2,036,596 | $13.66M | 0 | 1 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 1,995,179 | $221.53M | 1 | 0 | 1 | 1 | 3 |
| GILD | GILEAD SCIENCES INC | 1,922,867 | -$36.36M | 1 | 4 | 3 | 0 | 10 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,568,990 | $173.17M | 0 | 1 | 1 | 0 | 3 |
| TMO | THERMO FISHER SCIENTIFIC INC | 1,383,829 | $291.54M | 0 | 2 | 7 | 0 | 14 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1,161,909 | $135.06M | 1 | 1 | 3 | 0 | 8 |
| VCYT | VERACYTE INC | 949,365 | $19.49M | 0 | 1 | 0 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 910,608 | $47.51M | 0 | 1 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 859,705 | $10.43M | 0 | 1 | 0 | 0 | 2 |
| CNC | CENTENE CORP | 838,337 | $123.64M | 2 | 1 | 1 | 0 | 5 |
| CTLT | CATALENT INC | 789,189 | $34.60M | 0 | 1 | 1 | 0 | 3 |
| COR | CENCORA INC | 633,653 | $48.18M | 0 | 2 | 0 | 1 | 2 |
| ILMN | ILLUMINA INC | 582,028 | $173.34M | 1 | 1 | 0 | 0 | 3 |
| MCK | MCKESSON CORP | 485,437 | $5.52M | 0 | 3 | 1 | 0 | 6 |
| EDIT | EDITAS MEDICINE INC | 457,461 | $23.51M | 0 | 1 | 1 | 0 | 2 |
| HOLX | HOLOGIC INC | 449,075 | $57.36M | 0 | 1 | 2 | 0 | 4 |
| WAT | WATERS CORP | 446,308 | $55.38M | 0 | 3 | 1 | 0 | 5 |
| CERS | CERUS CORP | 443,387 | $9.21M | 0 | 1 | 0 | 0 | 1 |
| CPIX | CUMBERLAND PHARMACEUTICALS | 291,126 | $1.23M | 0 | 1 | 0 | 0 | 2 |
| ZTS | ZOETIS INC | 240,590 | $42.48M | 0 | 2 | 1 | 0 | 5 |
| IQV | IQVIA HOLDINGS INC | 229,190 | $39.79M | 0 | 1 | 0 | 0 | 2 |
| AMGN | AMGEN INC | 222,893 | $61.16M | 0 | 4 | 1 | 1 | 8 |
| CLLS | CELLECTIS - ADR | 156,666 | $4.15M | 0 | 1 | 0 | 0 | 1 |
| DVA | DAVITA INC | 140,743 | $144.75M | 1 | 0 | 0 | 0 | 3 |
| INSP | INSPIRE MEDICAL SYSTEMS INC | 118,100 | $4.21M | 1 | 0 | 0 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | 84,873 | -$119.24M | 0 | 6 | 7 | 0 | 18 |
| ANAB | ANAPTYSBIO INC | 83,866 | -$9.24M | 0 | 1 | 0 | 0 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 79,750 | $28.41M | 0 | 2 | 0 | 0 | 3 |
| SIGA | SIGA TECHNOLOGIES INC | 75,000 | $446.00K | 1 | 0 | 0 | 0 | 1 |
| BLUE | BLUEBIRD BIO INC | 65,922 | $7.62M | 0 | 1 | 0 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 57,527 | $470.00K | 0 | 1 | 0 | 0 | 1 |
| BIIB | BIOGEN INC | 55,013 | $16.66M | 1 | 1 | 1 | 0 | 6 |
| A | AGILENT TECHNOLOGIES INC | 45,844 | -$16.83M | 1 | 0 | 1 | 0 | 4 |
| GMAB | GENMAB A/S -SP ADR | 44,181 | -$138.00K | 0 | 1 | 0 | 0 | 1 |
| MD | PEDIATRIX MEDICAL GROUP INC | 41,088 | -$26.12M | 0 | 1 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 38,512 | $3.85M | 0 | 1 | 0 | 0 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 20,750 | -$18.73M | 0 | 2 | 0 | 0 | 5 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 19,550 | -$9.00K | 0 | 1 | 0 | 0 | 1 |
| SRNE | SORRENTO THERAPEUTICS INC | 10,000 | $174.00K | 0 | 1 | 0 | 0 | 2 |
| HCSG | HEALTHCARE SERVICES GROUP | 4,781 | $199.00K | 0 | 2 | 0 | 0 | 3 |
| DGX | QUEST DIAGNOSTICS INC | 3,157 | $2.67M | 0 | 1 | 0 | 0 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 2,086 | $26.00K | 0 | 1 | 0 | 0 | 2 |
| LMAT | LEMAITRE VASCULAR INC | 1,941 | $43.00K | 0 | 1 | 0 | 0 | 2 |
| IDXX | IDEXX LABORATORIES INC | 1,893 | $118.15M | 0 | 2 | 0 | 0 | 5 |
| EW | EDWARDS LIFESCIENCES CORP | 928 | $20.46M | 1 | 1 | 2 | 0 | 5 |
Frequently asked questions about Most bought healthcare stocks in Q2 2018
What are the most bought Healthcare stocks in Q2 2018?
The most bought healthcare stocks in Q2 2018 are those with the largest increase in reported share counts across institutional investors compared to Q1 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2018?
Among filers in this sector, net additions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), ELI LILLY & CO (LLY), TEVA PHARMACEUTICAL-SP ADR (TEVA), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.